Future Perspectives on Global Cancer Monitoring
The Minimal Residual Disease Testing Market Global Outlook for 2026 reflects a transformative period where molecular diagnostics are no longer confined to specialized research centers but are becoming a global standard. With the rise of hematological malignancies and the expanding application of MRD in solid tumors, international health systems are prioritizing high-sensitivity testing to...
0 Commentarii 0 Distribuiri 88 Views 0 previzualizare
Sponsor